RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • A complete review of empagliflozin: Most specific and potent SGLT2 inhibitor used for the treatment of type 2 diabetes mellitus.

A complete review of empagliflozin: Most specific and potent SGLT2 inhibitor used for the treatment of type 2 diabetes mellitus.

Add to Collection
2019 May-Jun Review Fist_Author_Year_PM

Full Author : ['Chawla, Gita', 'Chaudhary, Krishna Kr']
Journal Title : Diabetes & metabolic syndrome
Chapter : Section3
Journal Year : 2019
Cited by : Not Available

Sodium-glucose co-transporter 2 (SGLT2) inhibitors are the latest class of drugs to be introduced for the treatment of type 2 diabetes mellitus (T2DM). They reduce hyperglycemia by increasing urinary glucose excretion and exert favorable effects beyond gl.....

Keywords : ["type diabetes mellitus", "potent inhibitor use", "complete review", "treatment", "specific", "empagliflozin"]